INSIGHTS ON UPSTREAM MANUFACTURING

  • Exciting Advances In Cell Line Development
    11/5/2026

    In this segment from the Bioprocess Online Live event, “Critical Decisions Driving Next-Generation Cell Line Development,” panelists Ted Peters, Ph.D., and Ronan O’Kennedy, Ph.D., discuss the trends or advancements that excite them the most, which include a deeper understanding of CHO cell biology and the industry-wide push towards continuous manufacturing.

  • When To Shift To A Master Cell Bank
    11/5/2026

    In this segment from the Bioprocess Online Live event, “Critical Decisions Driving Next-Generation Cell Line Development,” panelists Ted Peters, Ph.D., and Ronan O’Kennedy, Ph.D., answer audience questions pertaining to master cell banking (MCB) and technology transfer.

  • Clone Selection And CMC Documentation
    11/5/2026

    This closing segment from the Bioprocess Online Live event, “Critical Decisions Driving Next-Generation Cell Line Development,” focuses on clone selection and the regulatory importance of demonstrating clonality in cell line development (CLD). Panelists Ted Peters, Ph.D., and Ronan O’Kennedy, Ph.D., also share their thoughts on Operation Trial Blazer.

  • Properly Documenting Early Cell Line Development
    11/5/2026

    In this segment from the Bioprocess Online Live event, “Critical Decisions Driving Next-Generation Cell Line Development,” panelists Ted Peters, Ph.D., and Ronan O’Kennedy, Ph.D., agree that documentation (or rather, failing to document) is the most common issue they’ve encountered teams make in cell line development (CLD). They both believe teams should spend more time correctly documenting early CLD and understanding regulatory requirements ahead of IND submission.

UPSTREAM MANUFACTURING SOLUTIONS